Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and Neurodegenerative Diseases

adenosine diphosphate has been researched along with Neurodegenerative Diseases in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's2 (40.00)24.3611
2020's2 (40.00)2.80

Authors

AuthorsStudies
Bretonneau, C; Labarre, A; Livernoche, R; Maios, C; Parker, JA; Tossing, G1
Lai, MC; Liou, SS; Liu, IM; Liu, WY1
Abramov, AY; Arber, C; Bartolome, F; Carro, E; de Vicente, M; Gandhi, S; Houlden, H; Ludtmann, MHR; Preza, E; Wray, S1
Hoffmann, K; von Kügelgen, I1
Dolder, M; Schlattner, U; Speer, O; Wallimann, T; Walzel, B1

Reviews

1 review(s) available for adenosine diphosphate and Neurodegenerative Diseases

ArticleYear
Pharmacology and structure of P2Y receptors.
    Neuropharmacology, 2016, Volume: 104

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Brain; Cardiovascular Diseases; Humans; Microglia; Neurodegenerative Diseases; Neurons; Platelet Aggregation; Purinergic P2Y Receptor Agonists; Purinergic P2Y Receptor Antagonists; Receptors, Purinergic P2Y; Uridine Triphosphate

2016

Other Studies

4 other study(ies) available for adenosine diphosphate and Neurodegenerative Diseases

ArticleYear
Genetic and pharmacological PARP inhibition reduces axonal degeneration in C. elegans models of ALS.
    Human molecular genetics, 2022, 09-29, Volume: 31, Issue:19

    Topics: Adenosine Diphosphate; Amyotrophic Lateral Sclerosis; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; MAP Kinase Kinase Kinases; Neurodegenerative Diseases; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Ribose

2022
A Bibenzyl Component Moscatilin Mitigates Glycation-Mediated Damages in an SH-SY5Y Cell Model of Neurodegenerative Diseases through AMPK Activation and RAGE/NF-
    Molecules (Basel, Switzerland), 2020, Oct-07, Volume: 25, Issue:19

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; AMP-Activated Protein Kinases; Benzyl Compounds; Blotting, Western; Cell Survival; DNA Fragmentation; Glutathione; Glycation End Products, Advanced; Humans; Lipid Peroxidation; Membrane Potential, Mitochondrial; Neurodegenerative Diseases; NF-kappa B; Oxidative Stress; Reactive Oxygen Species; Receptor for Advanced Glycation End Products

2020
Mutations in valosin-containing protein (VCP) decrease ADP/ATP translocation across the mitochondrial membrane and impair energy metabolism in human neurons.
    The Journal of biological chemistry, 2017, 05-26, Volume: 292, Issue:21

    Topics: Adenosine Diphosphate; Adenosine Triphosphatases; Adenosine Triphosphate; Biological Transport, Active; Cell Cycle Proteins; Cell Line, Tumor; Humans; Induced Pluripotent Stem Cells; Mitochondrial ADP, ATP Translocases; Mitochondrial Membranes; Mutation; Neurodegenerative Diseases; Neurons; Proteostasis Deficiencies; Valosin Containing Protein

2017
Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation.
    The Journal of biological chemistry, 2003, May-16, Volume: 278, Issue:20

    Topics: Adenine; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Calcium; Cell Survival; Chromatography, Thin Layer; Creatine; Creatine Kinase; Creatinine; Dose-Response Relationship, Drug; Guanidines; Ion Channels; Liver; Magnesium; Mice; Mice, Transgenic; Mitochondria; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Models, Biological; Neurodegenerative Diseases; Oxygen; Oxygen Consumption; Phosphocreatine; Phosphorylation; Propionates; Protein Binding; Time Factors

2003